Sharon joined CellCentric in April 2025.  

Sharon has extensive experience within CMC functions including late-stage project leadership (Phase II to post commercialization).  During the last 15 years at GSK she gained experience within primary and secondary process development and manufacture, specializing in drug product.   

Sharon brings a wealth of experience from both biotech and CDMO settings having held accountability for external manufacturing of outsourced products and regulatory strategy as a biotech CMC director.  As the Senior Director at the CDMO, Pharmaron she was instrumental in initiating and establishing their drug product business in the UK.  She has a PhD in Chemical Engineering from Imperial College and is a Chartered Fellow of the IChemE.